Log in

IRIDEX Stock Price, Forecast & Analysis (NASDAQ:IRIX)

$2.02
-0.01 (-0.49 %)
(As of 11/15/2019 04:00 PM ET)
Today's Range
$2.00
Now: $2.02
$2.02
50-Day Range
$1.77
MA: $1.89
$2.20
52-Week Range
$1.50
Now: $2.02
$5.69
Volume45,300 shs
Average Volume49,762 shs
Market Capitalization$27.84 million
P/E RatioN/A
Dividend YieldN/A
Beta0.8
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. The company offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser systems, which are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. Read More…

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorComputer and Technology
Current SymbolNASDAQ:IRIX
CUSIPN/A
Phone650-940-4700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$42.60 million
Book Value$1.74 per share

Profitability

Net Income$-12,810,000.00

Miscellaneous

EmployeesN/A
Market Cap$27.84 million
Next Earnings Date3/3/2020 (Estimated)
OptionableNot Optionable

Receive IRIX News and Ratings via Email

Sign-up to receive the latest news and ratings for IRIX and its competitors with MarketBeat's FREE daily newsletter.


IRIDEX (NASDAQ:IRIX) Frequently Asked Questions

What is IRIDEX's stock symbol?

IRIDEX trades on the NASDAQ under the ticker symbol "IRIX."

How were IRIDEX's earnings last quarter?

IRIDEX Co. (NASDAQ:IRIX) issued its quarterly earnings data on Thursday, November, 7th. The medical equipment provider reported ($0.13) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.18) by $0.05. The medical equipment provider earned $10.66 million during the quarter, compared to analysts' expectations of $10.08 million. IRIDEX had a negative net margin of 23.42% and a negative return on equity of 37.78%. View IRIDEX's Earnings History.

When is IRIDEX's next earnings date?

IRIDEX is scheduled to release their next quarterly earnings announcement on Tuesday, March 3rd 2020. View Earnings Estimates for IRIDEX.

What price target have analysts set for IRIX?

2 Wall Street analysts have issued 12-month target prices for IRIDEX's stock. Their forecasts range from $7.00 to $7.00. On average, they anticipate IRIDEX's stock price to reach $7.00 in the next year. This suggests a possible upside of 246.5% from the stock's current price. View Analyst Price Targets for IRIDEX.

What is the consensus analysts' recommendation for IRIDEX?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for IRIDEX in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for IRIDEX.

Has IRIDEX been receiving favorable news coverage?

Media headlines about IRIX stock have trended positive recently, InfoTrie Sentiment reports. InfoTrie ranks the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. IRIDEX earned a news sentiment score of 2.7 on InfoTrie's scale. They also gave news headlines about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the next several days. View News Stories for IRIDEX.

Are investors shorting IRIDEX?

IRIDEX saw a drop in short interest in October. As of October 31st, there was short interest totalling 77,700 shares, a drop of 93.8% from the September 30th total of 1,250,000 shares. Based on an average daily volume of 95,000 shares, the days-to-cover ratio is currently 0.8 days. Approximately 0.7% of the shares of the stock are sold short. View IRIDEX's Current Options Chain.

Who are some of IRIDEX's key competitors?

What other stocks do shareholders of IRIDEX own?

Who are IRIDEX's key executives?

IRIDEX's management team includes the folowing people:
  • Mr. William M. Moore, Chairman of Directors, Pres & CEO (Age 70)
  • Dr. George R. Marcellino, VP of Clinical Affairs (Age 70)
  • Mr. Romeo R. Dizon, VP of Fin.
  • Ms. Leigh Salvo, Head of Investor Relations
  • Mr. Timothy D. Buckley, VP of Marketing & North American Sales (Age 44)

Who are IRIDEX's major shareholders?

IRIDEX's stock is owned by many different of institutional and retail investors. Top institutional investors include Eidelman Virant Capital (0.86%), Perkins Capital Management Inc. (0.32%), Osborne Partners Capital Management LLC (0.19%) and Gabelli Funds LLC (0.15%). Company insiders that own IRIDEX stock include Associates & Paragon A Paragon, Robert Earle Grove, Romeo R Dizon, Scott Shuda and William M Moore. View Institutional Ownership Trends for IRIDEX.

Which major investors are selling IRIDEX stock?

IRIX stock was sold by a variety of institutional investors in the last quarter, including Perkins Capital Management Inc., Eidelman Virant Capital and Osborne Partners Capital Management LLC. View Insider Buying and Selling for IRIDEX.

Which major investors are buying IRIDEX stock?

IRIX stock was acquired by a variety of institutional investors in the last quarter, including Gabelli Funds LLC. Company insiders that have bought IRIDEX stock in the last two years include Associates & Paragon A Paragon, Robert Earle Grove, Scott Shuda and William M Moore. View Insider Buying and Selling for IRIDEX.

How do I buy shares of IRIDEX?

Shares of IRIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is IRIDEX's stock price today?

One share of IRIX stock can currently be purchased for approximately $2.02.

How big of a company is IRIDEX?

IRIDEX has a market capitalization of $27.84 million and generates $42.60 million in revenue each year. The medical equipment provider earns $-12,810,000.00 in net income (profit) each year or ($1.05) on an earnings per share basis. View Additional Information About IRIDEX.

What is IRIDEX's official website?

The official website for IRIDEX is http://www.iridex.com/.

How can I contact IRIDEX?

IRIDEX's mailing address is 1212 Terra Bella Avenue, Mountain View CA, 94043. The medical equipment provider can be reached via phone at 650-940-4700 or via email at [email protected]


MarketBeat Community Rating for IRIDEX (NASDAQ IRIX)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  170 (Vote Outperform)
Underperform Votes:  165 (Vote Underperform)
Total Votes:  335
MarketBeat's community ratings are surveys of what our community members think about IRIDEX and other stocks. Vote "Outperform" if you believe IRIX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IRIX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel